Next-generation sequencing in oncology: genetic diagnosis, risk prediction and cancer classification

R Kamps, RD Brandão, BJ van den Bosch… - International journal of …, 2017 - mdpi.com
Next-generation sequencing (NGS) technology has expanded in the last decades with
significant improvements in the reliability, sequencing chemistry, pipeline analyses, data …

[HTML][HTML] The proportion of endometrial cancers associated with Lynch syndrome: a systematic review of the literature and meta-analysis

NAJ Ryan, MA Glaire, D Blake, M Cabrera-Dandy… - Genetics in …, 2019 - Elsevier
Purpose Endometrial cancer (EC) is often the sentinel cancer in women with Lynch
syndrome (LS). However, efforts to implement universal LS screening in EC patients have …

Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the …

C Cremolini, C Antoniotti, D Rossini, S Lonardi… - The Lancet …, 2020 - thelancet.com
Background The triplet FOLFOXIRI (fluorouracil, leucovorin, oxaliplatin, and irinotecan) plus
bevacizumab showed improved outcomes for patients with metastatic colorectal cancer …

FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and …

C Cremolini, F Loupakis, C Antoniotti, C Lupi… - The Lancet …, 2015 - thelancet.com
Background In the TRIBE study, FOLFOXIRI (fluorouracil, leucovorin, oxaliplatin, and
irinotecan) plus bevacizumab significantly improved progression-free survival of patients …

Deleterious germline mutations in patients with apparently sporadic pancreatic adenocarcinoma

K Shindo, J Yu, M Suenaga… - Journal of Clinical …, 2017 - ascopubs.org
Purpose Deleterious germline mutations contribute to pancreatic cancer susceptibility and
are well documented in families in which multiple members have had pancreatic cancer …

Cancer Risks for PMS2-Associated Lynch Syndrome

SW Ten Broeke, HM van der Klift, CMJ Tops… - Journal of Clinical …, 2018 - ascopubs.org
Purpose Lynch syndrome due to pathogenic variants in the DNA mismatch repair genes
MLH1, MSH2, and MSH6 is predominantly associated with colorectal and endometrial …

Familial adenomatous polyposis syndrome: an update and review of extraintestinal manifestations

P Dinarvand, EP Davaro, JV Doan… - … of pathology & …, 2019 - meridian.allenpress.com
Context.—Familial adenomatous polyposis (FAP) is a rare genetic disorder with autosomal
dominant inheritance, defined by numerous adenomatous polyps, which inevitably progress …

The rising incidence of younger patients with colorectal cancer: questions about screening, biology, and treatment

LC Connell, JM Mota, MI Braghiroli, PM Hoff - Current treatment options in …, 2017 - Springer
Opinion statement Colorectal cancer (CRC) is the third leading cancer diagnosed globally
and an important cause of cancer-related mortality. Of interest, while we have witnessed a …

Hereditary colorectal polyposis and cancer syndromes: a primer on diagnosis and management

P Kanth, J Grimmett, M Champine, R Burt… - Official journal of the …, 2017 - journals.lww.com
Colorectal cancer (CRC) is the fourth most common cancer amongst men and women.
Between 3 and 6% of all CRCs are attributed to well-defined inherited syndromes, including …

Role of genetic testing for inherited prostate cancer risk: Philadelphia Prostate Cancer Consensus Conference 2017

VN Giri, KE Knudsen, WK Kelly, W Abida… - Journal of Clinical …, 2018 - ascopubs.org
Purpose Guidelines are limited for genetic testing for prostate cancer (PCA). The goal of this
conference was to develop an expert consensus-driven working framework for …